Literature DB >> 10807449

Distinct hemodynamic profiles in patients with vasovagal syncope: a heterogeneous population.

W K Shen1, P A Low, R F Rea, C M Lohse, D O Hodge, S C Hammill.   

Abstract

OBJECTIVE: The objective was to investigate mechanisms of vasovagal syncope by identifying laboratory techniques that characterize cardiovascular profiles in patients with vasovagal syncope.
BACKGROUND: The triggering mechanisms of vasovagal syncope are complex. The patient population is likely heterogeneous. We hypothesized that distinct hemodynamic profiles are definable with provocative maneuvers.
METHODS: Three groups of subjects were matched for age and gender: 16 patients with a history of syncope and an inducible vasovagal response during passive tilt table testing (70 degrees, 45 min, group I), 16 with a history of syncope, negative passive tilt table testing but positive isoproterenol tilt table testing (0.05 microg/kg per min, 70 degrees, 10 min, group II), and 16 control subjects. Beat-to-beat hemodynamic functions were determined noninvasively by photo-plethysmography and impedance cardiography.
RESULTS: At baseline, hemodynamic functions were not different among the three groups (supine). In response to tilt before any symptoms developed, total peripheral resistance decreased 9% +/- 14% in group I from baseline supine to tilt position but increased 27% +/- 18% in group II and 28% +/- 17% in controls (p < 0.001). Responses to isoproterenol were not significantly different between group II and controls in supine position. In response to tilt during isoproterenol infusion before any symptoms developed, total peripheral resistance decreased 24% +/- 20% in group II and increased 20% +/- 48% in controls (p = 0.002).
CONCLUSIONS: Group I patients may have impaired ability to increase vascular resistance during orthostatic stress. The inability to overcome isoproterenol-induced vasodilatation during tilt is important in triggering a vasovagal response in group II patients. These data suggest that the population with vasovagal response is heterogeneous. Distinct hemodynamic profiles in response to various provocative maneuvers are definable with noninvasive, continuous monitoring techniques.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2000        PMID: 10807449     DOI: 10.1016/s0735-1097(00)00567-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

1.  Clinical predictors of head-up tilt test outcome during the nitroglycerin phase.

Authors:  Massimo Iacoviello; Cinzia Forleo; Pietro Guida; Marco Matteo Ciccone; Sandro Sorrentino; Valentina D'Andria; Mariligia Panunzio; Stefano Favale
Journal:  Clin Auton Res       Date:  2009-06-30       Impact factor: 4.435

2.  Pulse wave analysis of the aortic pressure waveform in patients with vasovagal syncope.

Authors:  Simon Pecha; Samer Hakmi; Iris Wilke; Yalin Yildirim; Boris Hoffmann; Hermann Reichenspurner; Stephan Willems; Yskert von Kodolitsch; Ali Aydin
Journal:  Heart Vessels       Date:  2014-08-28       Impact factor: 2.037

Review 3.  Wearable sensors in syncope management.

Authors:  Christian Meyer; Paulo Carvalho; Christoph Brinkmeyer; Malte Kelm; Ricardo Couceiro; Jens Mühlsteff
Journal:  Med Sci Monit       Date:  2015-01-22

4.  Early hemodynamic response to the tilt test in patients with syncope.

Authors:  Edward Koźluk; Gerard Cybulski; Agnieszka Piątkowska; Inga Zastawna; Wiktor Niewiadomski; Anna Strasz; Anna Gąsiorowska; Maciej Kempa; Dariusz Kozłowski; Grzegorz Opolski
Journal:  Arch Med Sci       Date:  2014-12-22       Impact factor: 3.318

5.  The complexity of hemodynamic response to the tilt test with and without nitroglycerine provocation in patients with vasovagal syncope.

Authors:  Katarzyna Buszko; Agnieszka Piątkowska; Edward Koźluk; Tomasz Fabiszak; Grzegorz Opolski
Journal:  Sci Rep       Date:  2018-09-28       Impact factor: 4.379

6.  Autonomic function tests: some clinical applications.

Authors:  Phillip A Low; Victoria A Tomalia; Ki-Jong Park
Journal:  J Clin Neurol       Date:  2013-01-03       Impact factor: 3.077

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.